Allen Meglin - 19 Aug 2022 Form 4 Insider Report for Organicell Regenerative Medicine, Inc. (OCEL)

Role
Director
Signature
/s/ Allen Meglin
Issuer symbol
OCEL
Transactions as of
19 Aug 2022
Transactions value $
$0
Form type
4
Filing time
24 Aug 2022, 16:54:51 UTC
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding OCEL Common Stock 14.6M 19 Aug 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Allen Meglin is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The Reporting Person is filing this Form 4 to report his resignation as a director of the Issuer effective August 19, 2022 and his beneficially owned holdings in the Issuer as of such date.